187 related articles for article (PubMed ID: 32681389)
41. Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade.
Shen K; Ji L; Lu B; Xu C; Gong C; Morahan G; Wang Z
Chem Biol Interact; 2014 Jul; 218():99-106. PubMed ID: 24814888
[TBL] [Abstract][Full Text] [Related]
42. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
Farhan MA; Azad AK; Touret N; Murray AG
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
[TBL] [Abstract][Full Text] [Related]
43. A heat-shock protein axis regulates VEGFR2 proteolysis, blood vessel development and repair.
Bruns AF; Yuldasheva N; Latham AM; Bao L; Pellet-Many C; Frankel P; Stephen SL; Howell GJ; Wheatcroft SB; Kearney MT; Zachary IC; Ponnambalam S
PLoS One; 2012; 7(11):e48539. PubMed ID: 23139789
[TBL] [Abstract][Full Text] [Related]
44. Pleiotrophin exerts its migration and invasion effect through the neuropilin-1 pathway.
Elahouel R; Blanc C; Carpentier G; Frechault S; Cascone I; Destouches D; Delbé J; Courty J; Hamma-Kourbali Y
Neoplasia; 2015 Aug; 17(8):613-24. PubMed ID: 26408254
[TBL] [Abstract][Full Text] [Related]
45. Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.
Somanath PR; Malinin NL; Byzova TV
Angiogenesis; 2009; 12(2):177-85. PubMed ID: 19267251
[TBL] [Abstract][Full Text] [Related]
46. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
47. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
48. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
[TBL] [Abstract][Full Text] [Related]
49. Effects of auriculasin on vascular endothelial growth factor (VEGF)-induced angiogenesis via regulation of VEGF receptor 2 signaling pathways in vitro and in vivo.
Cho HD; Moon KD; Park KH; Lee YS; Seo KI
Food Chem Toxicol; 2018 Nov; 121():612-621. PubMed ID: 30236598
[TBL] [Abstract][Full Text] [Related]
50. The Role of Heparan Sulfate and Neuropilin 2 in VEGFA Signaling in Human Endothelial Tip Cells and Non-Tip Cells during Angiogenesis In Vitro.
Dallinga MG; Habani YI; Schimmel AWM; Dallinga-Thie GM; van Noorden CJF; Klaassen I; Schlingemann RO
Cells; 2021 Apr; 10(4):. PubMed ID: 33923753
[TBL] [Abstract][Full Text] [Related]
51. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
[TBL] [Abstract][Full Text] [Related]
52. Identification of VEGFR2 as the Histatin-1 receptor in endothelial cells.
Mateluna C; Torres P; Rodriguez-Peña M; Silva P; Matthies DJ; Criollo A; Bikker FJ; Bolscher JGM; Wilson CAM; Zapata-Torres G; Torres VA
Biochem Pharmacol; 2022 Jul; 201():115079. PubMed ID: 35551916
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
54. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis.
Li R; Luo M; Ren M; Chen N; Xia J; Deng X; Zeng M; Yan K; Luo T; Wu J
J Vasc Res; 2014; 51(2):110-7. PubMed ID: 24603119
[TBL] [Abstract][Full Text] [Related]
55. Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis.
Rahman HNA; Wu H; Dong Y; Pasula S; Wen A; Sun Y; Brophy ML; Tessneer KL; Cai X; McManus J; Chang B; Kwak S; Rahman NS; Xu W; Fernandes C; Mcdaniel JM; Xia L; Smith L; Srinivasan RS; Chen H
Circ Res; 2016 Mar; 118(6):957-969. PubMed ID: 26879230
[TBL] [Abstract][Full Text] [Related]
56. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
[TBL] [Abstract][Full Text] [Related]
57. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
58. The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.
Herkenne S; Paques C; Nivelles O; Lion M; Bajou K; Pollenus T; Fontaine M; Carmeliet P; Martial JA; Nguyen NQ; Struman I
Sci Signal; 2015 Nov; 8(403):ra117. PubMed ID: 26577922
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis impairment in diabetes: role of methylglyoxal-induced receptor for advanced glycation endproducts, autophagy and vascular endothelial growth factor receptor 2.
Liu H; Yu S; Zhang H; Xu J
PLoS One; 2012; 7(10):e46720. PubMed ID: 23056421
[TBL] [Abstract][Full Text] [Related]
60. Temporal Dynamics of VEGFA-Induced VEGFR2/FAK Co-Localization Depend on SHB.
Pietilä I; Van Mourik D; Tamelander A; Kriz V; Claesson-Welsh L; Tengholm A; Welsh M
Cells; 2019 Dec; 8(12):. PubMed ID: 31847469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
